We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Transfusion Requirements in Critical Care A Pilot Study

Paul C. Hébert, MD, MHSc, FRCPC; George Wells, PhD; John Marshall, MD, FRCSC; Claudio Martin, MD, MSc, FRCPC; Martin Tweeddale, MD, PhD, FRCPC; Giuseppe Pagliarello, MD, FRCSC; Morris Blajchman, MD, FRCPC; G. Wood, MD; R. Hill, MD, MSc; J. Granton, MD; J. Calvin, MD; D. Cook, MD, MSc; W. Demajo, MD; P. Dodek, MD; C. Bradley, MD; L. Champion, MD; H. Devitt, MD; G. Ford, MD; G. Fox, MD; M. Girotti, MD; R. Hall; P. Hebert; J. Hewson, MD; H. Fuller, MD; B. Guslits, MD; S. Hamilton, MD; M. Heule, MD; D. Heyland, MD; T. Hillers, MD, MSc; P. Houston, MD; J. Kronick, MD; A. Laupacis, MD, MSc; D. Leasa, MD; R. Hodder, MD, MSc; J. LaCroix, MD; N. Lazar, MD; S. Magder, MD; J. Marshall; S. Moffatt, MD; L. Oppenheimer, MD; L. Passerini, MD; P. Powles, MD; R. Mclntyre, MD; T. Noseworthy, MD, MHA; J. Pagliarello, MD; S. Peters, MD; D. Roberts, MD; T. Rosenal, MD; J. Russell, MD; J. D. Sandham, MD; P. Walker, MD; P. Roy, MD; R. Saeschke, MD; D. W. Shragge, MD; T. R. Todd, MD; J. Watters, MD; T. Winton, MD; M. Tweeddale; A. Slutsky, MD; B. Wilson, MD; A. Kirby, MD; G. Rocker, MD; K. Inman, MSc; P. Boiteau, MD; P. Kernerman, MD; G. Doig, DVM; T. Stewart, MD
JAMA. 1995;273(18):1439-1444. doi:10.1001/jama.1995.03520420055038.
Text Size: A A A
Published online


Objective.  —To evaluate the effects of a restrictive and a liberal red blood cell (RBC) transfusion strategy on mortality and morbidity in critically ill patients.

Study Design.  —Multicenter, prospective, randomized clinical trial.

Patient Population.  —Sixty-nine normovolemic critically ill patients admitted to one of five tertiary level intensive care units with hemoglobin values less than 90 g/L within 72 hours of admission.

Interventions.  —Patients were randomly allocated to one of two RBC transfusion strategies. Hemoglobin values were maintained between 100 and 120 g/L in the liberal transfusion group and between 70 and 90 g/L in the restrictive group.

Results.  —Primary diagnosis and mean±SD age (58.6±15 vs 59.0±21 years) and Acute Physiology and Chronic Health Evaluation II score (20±6.2 vs 21 ±7.2) were similar in the restrictive and liberal groups, respectively. Daily hemoglobin values averaged 90 g/L in the restrictive group vs 109 g/L in the liberal group (P<.001). The restrictive group received 2.5 U per patient compared with 4.8 U per patient in the liberal group. This represents a 48% relative decrease (P<.001) in RBC units transfused per patient. The 30-day mortality rate was 24% in the restrictive group compared with 25% in the liberal group; the 95% confidence interval around the absolute difference was −19% to 21%. Similar observations were noted for intensive care unit mortality (P=.76) and 120-day mortality (P>.99). In addition, survival analysis comparing time until death in both groups did not reveal any significant difference (P=.93) between groups. Organ dysfunction scores were also similar (P=.44).

Conclusion.  —In this small randomized trial, neither mortality nor the development of organ dysfunction was affected by the transfusion strategy, which suggests that a more restrictive approach to the transfusion of RBCs may be safe in critically ill patients. However, the study lacked power to detect small but clinically significant differences. Therefore, further investigations of RBC transfusion strategies are warranted.(JAMA. 1995;273:1439-1444)


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...